| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/10/2012 | US8153631 Triazole compounds and uses related thereto |
| 04/10/2012 | US8153588 Methods useful in the treatment of bone resorption diseases |
| 04/10/2012 | US8153398 Polynucleotides encoding signal peptide-containing molecules |
| 04/10/2012 | US8153384 Marks as modifiers of the p53 pathway and methods of use |
| 04/10/2012 | US8153141 Immunostimulatory G, U-containing oligoribonucleotides |
| 04/10/2012 | US8153113 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 04/10/2012 | CA2662967C Medicinal composition |
| 04/10/2012 | CA2632567C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 04/10/2012 | CA2486308C Hepatitis c virus inhibitors |
| 04/10/2012 | CA2477857C Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/10/2012 | CA2446506C Methods for treating delirium using glucocorticoid receptor-specific antagonists |
| 04/10/2012 | CA2378456C Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 04/10/2012 | CA2352783C Stimulation of t cells against self antigens using ctla-4 blocking agents |
| 04/05/2012 | WO2012044577A1 Dual inhibitors of met and vegf for the treatment of castration resistant prostate cancer and osteoblastic bone metastases |
| 04/05/2012 | WO2012043838A1 Inhibitor for hepatitis c virus infection |
| 04/05/2012 | WO2012043747A1 Glioma treatment method, glioma examination method, method of delivering a desired material to a glioma, and drug used in said methods |
| 04/05/2012 | WO2012043052A1 Surgical cleaning solution |
| 04/05/2012 | WO2012042421A1 Method of treating abnormal cell growth |
| 04/05/2012 | WO2012041898A1 Combination of sglt2 inhibitor and a sugar compound for the treatment of diabetes |
| 04/05/2012 | WO2012041771A1 Combination therapy for treating hcv infection |
| 04/05/2012 | WO2012012498A9 Use of trp channel agonists to treat infections |
| 04/05/2012 | US20120082715 Stabilized products, processes and devices for preparing the same |
| 04/05/2012 | CA2813093A1 Combination therapy for treating hcv infection |
| 04/05/2012 | CA2812744A1 Dual inhibitors of met and vegf for the treatment of castration resistant prostate cancer and osteoblastic bone metastases |
| 04/04/2012 | EP2436396A1 Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder |
| 04/04/2012 | EP2436390A1 Topical Anesthetic Uses of Szeto-Schiller Peptides |
| 04/04/2012 | EP2435081A1 A therapeutic combination comprising a pulmonary surfactant and a steroid |
| 04/04/2012 | EP2435080A2 Pharmaceutical compositions for the treatment of pain |
| 04/04/2012 | EP2435052A1 Solid oral dosage forms of lamivudine |
| 04/04/2012 | EP2435041A1 Therapeutic combination comprising a plk1 inhibitor and an antineoplastic agent |
| 04/04/2012 | EP2435035A1 Methods of enhancing selective serotonin reuptake inhibitor effects in mammals |
| 04/04/2012 | EP2435021A2 Use of a glycosaminoglycan fixed combination and chewable composition comprising said fixed combination |
| 04/04/2012 | EP1545495B1 P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient |
| 04/04/2012 | EP1411861B1 Biodegradable injectable implants and related methods of manufacture and use |
| 04/04/2012 | EP1397158B1 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS |
| 04/04/2012 | EP1316316B1 Preparations for oral administration |
| 04/04/2012 | CN1985993B 增强记忆力的复方制剂 Enhance memory FDC |
| 04/04/2012 | CN1911245B Metal compunds, mixed or sulphated, as phosphate binders |
| 04/04/2012 | CN1870993B 基于咪唑克生盐或其一种多晶型物的药物组合物 Pharmaceutical compositions based idazoxan salt or a polymorph of |
| 04/04/2012 | CN102405045A 利用sns-595 治疗具有降低的brca2 活性的癌症对象的方法 Treatment using sns-595 having a reduced activity of a cancer brca2 object methods |
| 04/04/2012 | CN102397552A 一种含喹诺酮类的药物复合制剂及其制备方法和应用 A drug complex and its preparation method and application containing quinolones |
| 04/04/2012 | CN102397551A 包括罗格列酮和另一种抗糖尿病药的新组合物 Including rosiglitazone and another anti-diabetic drugs new compositions |
| 04/04/2012 | CN102397550A 一组由阿司匹林与雌激素组成的防治骨质疏松症的药物组合物 A group of osteoporosis prevention drug composition from the composition of aspirin and estrogen |
| 04/04/2012 | CN102397549A 用于治疗癌症的医药组合物 For a pharmaceutical composition for the treatment of cancer |
| 04/04/2012 | CN102397548A Medicinal composition containing arctigenin and medical application thereof |
| 04/04/2012 | CN102397547A Anti-cancer pharmaceutical composition |
| 04/04/2012 | CN102397546A 一种用于嗅觉或味觉敏感型动物的药物给药方法 Drug administration method for smell or taste-sensitive animals |
| 04/04/2012 | CN102397424A Application of areca nut extract in preparing weight-reducing and fat-lowering medicines or preparing medicines with lipase activity inhibiting effect |
| 04/04/2012 | CN102397344A Application of Chinese medicinal herb fleece-flower root extract to preparing weight-losing lipopenicillinase drugs or preparing drugs having lipase activity inhibitory action |
| 04/04/2012 | CN102397320A Application of Chinese medicinal herb suberect spatholobus stem extract to preparation of weight-reducing and fat-reducing medicament or preparation of medicament having lipase activity inhibiting effect |
| 04/04/2012 | CN102397304A Application of Chinese herbal medicine ginkgo biloba extract to preparation of medicament for reducing weight and lipid or preparation of medicament with lipase activity inhibitory action |
| 04/04/2012 | CN101711869B 喹诺酮类抗菌药物在银屑病治疗中的应用 Application of quinolone antibacterial drugs in the treatment of psoriasis |
| 04/03/2012 | USRE43298 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 04/03/2012 | US8148500 Method of preparing cysteine mutants of human recombinant GM-CSF |
| 04/03/2012 | US8148493 Method for inhibiting “melanoma inhibitory activity” MIA |
| 04/03/2012 | US8148347 Inhibition of interaction of PSD93 and PSDS95 with nNOS and NMDA receptors |
| 04/03/2012 | US8148337 Vaginal compositions for treating pelvic tissue infections and traumas |
| 04/03/2012 | US8148148 Neural progenitor cell populations |
| 04/03/2012 | US8148125 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 04/03/2012 | US8148109 Interferon-like proteins and uses thereof |
| 04/03/2012 | US8148080 Gene and protein relating to hepatocellular carcinoma and methods of use thereof |
| 04/03/2012 | US8147821 Using absorber; hydration |
| 04/03/2012 | US8147817 IL-33 in the treatment and diagnosis of diseases and disorders |
| 04/03/2012 | CA2513910C Compositon comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis |
| 04/03/2012 | CA2513281C Pharmaceutical combination for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 04/03/2012 | CA2501690C Amended recombinant cells (arcs) for the production and delivery of antiviral agents, adjuvants and vaccine accelerants |
| 04/03/2012 | CA2494569C An analgesic agent for newborn or fetal subjects |
| 04/03/2012 | CA2453115C Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus |
| 04/03/2012 | CA2435466C Use of il-18 inhibitors for the treatment and/or prevention of heart disease |
| 04/03/2012 | CA2434930C Treating pulmonary disorders with gaseous agent causing repletion of gsno |
| 04/03/2012 | CA2432792C Methods for modulating tumor growth and metastasis |
| 04/03/2012 | CA2398445C A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
| 03/29/2012 | WO2012040101A1 Compositions and methods for inducing migration by dendritic cells and an immune response |
| 03/29/2012 | WO2012039197A1 Agent for enhancing trail sensitivity |
| 03/29/2012 | WO2012039101A1 Composition for oral use |
| 03/29/2012 | WO2012038636A1 Xenon-based anesthetic gas composition usable during an endarterectomy involving the clamping of the carotid artery |
| 03/29/2012 | WO2012038590A1 Improved dietary substitution for treating or preventing cancer |
| 03/29/2012 | WO2012038333A2 Composition to act in prevention and to take care of diabetic foot |
| 03/29/2012 | WO2012018145A3 Agent for improving quality of life |
| 03/29/2012 | WO2012013756A3 Method for preparing tablets combining rifampicin, isoniazid, pyrazinamide and, optionally, ethambutol |
| 03/29/2012 | WO2011141822A3 Methods for induction, predictive diagnosis, and treatment of affective behaviors by modulation of ppar and rxr receptors |
| 03/29/2012 | US20120077877 Medium chain peroxycarboxylic acid compositions |
| 03/29/2012 | US20120076835 Hiv inhibiting pyrimidines derivatives |
| 03/29/2012 | US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 03/29/2012 | US20120076723 Devices and methods for the treatment of cancer |
| 03/29/2012 | US20120074026 Pharmaceutical foam |
| 03/29/2012 | CA2808662A1 Xenon-based anesthetic gas composition usable during an endarterectomy involving the clamping of the carotid artery |
| 03/28/2012 | EP2434282A2 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
| 03/28/2012 | EP2433623A1 Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism |
| 03/28/2012 | EP2432505A1 Combinations of immunostimulatory agents, oncolytic virus, and additional anticancer therapy |
| 03/28/2012 | EP2432453A2 Topical retinoid solutions |
| 03/28/2012 | EP2432318A1 Bimacrocyclic hcv ns3 protease inhibitors |
| 03/28/2012 | EP2186529B1 Synergic pharmaceutical composition, useful for inhibiting corneal and retinal neovascularization (angiogenesis), and in other organs, in a human being or animal |
| 03/28/2012 | EP1807065B1 Methods and compositions for treating nephrogenic diabetes insipidus |
| 03/28/2012 | EP1765362B1 Compositions and methods for treatment of neovascular diseases |
| 03/28/2012 | EP1579872B1 Body weight gain inhibitor |
| 03/28/2012 | EP1472234B1 Quinazolinone derivatives and their use as cb agonists |
| 03/28/2012 | EP1453508B1 Tempamine compositions and use against cellular oxidative damage |
| 03/28/2012 | EP1272197B2 Combination of lecithin with ascorbic acid |
| 03/28/2012 | CN1871024B Remedy and therapeutic method for periodontal diseases and pulpal diseases |